CSCIF · COSCIENS Biopharma Inc.
Market Cap
$4.96M
Shares
996,166
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-06 | — | |
| 6-K | 2026-06-23 | 2026-06-22 | |
| 6-K | 2026-06-18 | — | |
| 6-K | 2026-05-20 | — | |
| 6-K | 2026-05-12 | 2026-03-31 | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-05-08 | — | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-04-07 | — | |
| 6-K | 2026-03-25 | — | |
| 20-F | 2026-03-25 | 2025-12-31 | |
| 6-K | 2026-03-05 | — | |
| 6-K | 2026-02-13 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-11-14 | — | |
| 6-K | 2025-11-12 | — | |
| 6-K | 2025-11-12 | 2025-09-30 | |
| 6-K | 2025-08-14 | 2025-06-30 | |
| 6-K | 2025-08-14 | — | |
| 6-K | 2025-06-30 | — | |
| 6-K | 2025-06-09 | — | |
| 6-K | 2025-06-02 | 2025-05-30 | |
| 6-K | 2025-05-30 | — | |
| 6-K | 2025-05-27 | — | |
| 6-K | 2025-05-20 | — | |
| 6-K | 2025-05-13 | 2025-03-31 | |
| 6-K | 2025-05-13 | — | |
| 6-K | 2025-05-02 | — | |
| 6-K | 2025-04-14 | — | |
| 6-K | 2025-04-09 | — | |
| 20-F | 2025-04-09 | 2024-12-31 | |
| 6-K | 2025-04-02 | — | |
| 6-K | 2025-03-20 | 2025-03-19 | |
| 6-K | 2025-03-13 | — | |
| 6-K | 2024-12-23 | — | |
| 6-K | 2024-11-12 | — | |
| 6-K | 2024-11-12 | 2024-09-30 | |
| 6-K | 2024-10-08 | — | |
| 6-K | 2024-10-01 | — | |
| 6-K | 2024-09-23 | — | |
| 6-K | 2024-08-27 | — | |
| 6-K | 2024-08-13 | — | |
| 6-K | 2024-08-13 | 2024-06-30 | |
| 6-K | 2024-08-07 | 2024-08-06 | |
| 6-K | 2024-07-17 | 2024-07-16 | |
| 20-F/A | 2024-07-17 | 2023-12-31 | |
| 6-K | 2024-06-25 | — | |
| 6-K | 2024-06-13 | — | |
| 6-K | 2024-06-10 | — | |
| 6-K/A | 2024-05-30 | 2023-05-29 |
Showing 1–50 of 178 filings